Skip To Main Content

Áreas terapeúticas

Descubra la más reciente actualización sobre la evidencia científica y los datos basados en la vida real que se han recopilado en el campo de la epidemiología. Esta información incluye detalles sobre la carga que estas enfermedades imponen a las personas y a la sociedad en general, así como los métodos de control que se están implementando para hacer frente a estas situaciones.

También se aborda el impacto económico que tienen enfermedades como asma grave, cardiovascular, dermatitis atópica, diabetes o enfermedades raras, etc., en la vida de nuestra población. Estos elementos son fundamentales para comprender la magnitud del problema y para desarrollar estrategias efectivas que ayuden a mejorar la salud pública.

Ordenar por

Patología

Limpiar filtro
  • Filtros
Prof. Rory McCrimmon: Preventing Hypoglycaemia

Prof. Rory McCrimmon: Preventing Hypoglycaemia

Hypoglycaemia is a common and serious complication of diabetes, particularly affecting your patients on insulin therapy. It can have serious acute and long-term impacts.1,2

Prof. Rory McCrimmon on Why Hypoglycaemia Should be Top of Mind

Prof. Rory McCrimmon on Why Hypoglycaemia Should be Top of Mind

Hypoglycaemia is a common and serious complication of diabetes, particularly affecting your patients on insulin therapy. It can have serious acute and long-term impacts.1,2

Module 6: An update on RACGP guidelines - Mastering the Management of Type 2 Diabetes Part 2

Module 6: An update on RACGP guidelines - Mastering the Management of Type 2 Diabetes Part 2

The updated RACGP guidelines on the management of type 2 diabetes is an important primary care tool that provides GPs and other health professionals with information and recommendations based on the latest body of evidence.

Quest, Venture, and Traverse (DRI12544) Clinical Studies

Quest, Venture, and Traverse (DRI12544) Clinical Studies

VENTURE publication

VENTURE publication

Prof. Rory McCrimmon: Preventing Hypos: Insulin Optimisation

Prof. Rory McCrimmon: Preventing Hypos: Insulin Optimisation

Hypoglycaemia is a common and serious complication of diabetes, particularly affecting your patients on insulin therapy. It can have serious acute and long-term impacts.1,2

Module 5: An update on RACGP guidelines - Mastering the Management of Type 2 Diabetes Part 1

Module 5: An update on RACGP guidelines - Mastering the Management of Type 2 Diabetes Part 1

The updated RACGP guidelines on the management of type 2 diabetes is an important primary care tool that provides GPs and other health professionals with information and recommendations based on the latest body of evidence.

TRAVERSE publication

TRAVERSE publication

Prof. Rory McCrimmon: The impact of impaired Hypogylcaemia awareness

Prof. Rory McCrimmon: The impact of impaired Hypogylcaemia awareness

Hypoglycaemia is a common and serious complication of diabetes, particularly affecting your patients on insulin therapy. It can have serious acute and long-term impacts.1,2

Prof. Rory McCrimmon: What is impaired hypoglycaemia awareness?

Prof. Rory McCrimmon: What is impaired hypoglycaemia awareness?

Hypoglycaemia is a common and serious complication of diabetes, particularly affecting your patients on insulin therapy. It can have serious acute and long-term impacts.1,2

Prof. Rory McCrimmon: Why is Nocturnal Hypoglycaemia Important?

Prof. Rory McCrimmon: Why is Nocturnal Hypoglycaemia Important?

Hypoglycaemia is a common and serious complication of diabetes, particularly affecting your patients on insulin therapy. It can have serious acute and long-term impacts.1,2

Module 4: An update on RACGP guidelines - Diabetes and Cardiovascular Disease

Module 4: An update on RACGP guidelines - Diabetes and Cardiovascular Disease

The updated RACGP guidelines on the management of type 2 diabetes is an important primary care tool that provides GPs and other health professionals with information and recommendations based on the latest body of evidence.

Material diseñado por o para Sanofi Aventis de Colombia S.A., con fines educativos y dirigido a profesionales de la salud y personal administrativo del sector salud. Es estrictamente prohibido compartir este material con terceros.

Mayor información a disposición en el Departamento Médico:

En Colombia:

Sanofi-Aventis de Colombia S.A. Transversal 23 N° 97-73 - Edificio City Business. Piso 8. Bogotá D.C. Teléfono: 621 4400 - Fax: 744 4237

infomedica.colombia@sanofi.com

En Bolivia, Centro América y Caribe:

Sanofi-Aventis de Panamá S.A. Torre Evolution, piso 26, Calle 50 y Av. Aquilino de la Guardia Obarrio- Cuidad de Panamá, República de Panamá Telf.: (507) 382-9500. infomed.pac@sanofi.com

Sitio web: http://www.sanofi.com.pa/l/pa/sp/index.jsp

 

MAT-CO-2400825 V1.0 03/2024